EDAP TMS Set to Reveal Q2 2025 Financial Insights Soon

EDAP TMS SA to Announce Financial Results for Q2 2025
EDAP TMS SA (Nasdaq: EDAP), a pioneer in the realm of robotic energy-based therapies, is preparing to disclose its financial results for the second quarter, which concluded on June 30, 2025. The announcement is scheduled to take place before the markets commence trading on Thursday, August 28.
Upcoming Conference Call and Webcast
The announcement will be complemented by a conference call and a live webcast. This event will feature key executives from EDAP TMS, including Ryan Rhodes, the Chief Executive Officer, Ken Mobeck, the Chief Financial Officer, and François Dietsch, the Chief Accounting Officer. This is a valuable opportunity for investors to gain insights into EDAP TMS's performance and future prospects.
Details of the Conference Call
Scheduled for: Thursday, August 28
Time: 8:30 am EDT
Domestic Call Number: 1-800-274-8461
International Call Number: 1-203-518-9814
Passcode: EDAP
Webcast Access: Investors can participate in the webcast via the official EDAP TMS webpage.
About EDAP TMS
As a recognized leader in robotic energy-based therapies, EDAP TMS specializes in developing and manufacturing cutting-edge medical devices that are minimally invasive and harness ultrasound technology. They are particularly known for their innovative Focal One system, which operates as a premier prostate focal therapy under the guidance of urologists and has the potential application in other medical conditions beyond prostate cancer.
Company Contact Information
Blandine Confort
Investor Relations / Legal Affairs
EDAP TMS SA
+33 4 72 15 31 50
bconfort@edap-tms.com
Investor Relations Contact
John Fraunces
LifeSci Advisors, LLC
(917) 355-2395
jfraunces@lifesciadvisors.com
Frequently Asked Questions
When will EDAP TMS announce its Q2 2025 financial results?
The results will be announced on August 28, 2025, before the market opens.
Who will be presenting during the conference call?
The conference call will feature CEO Ryan Rhodes, CFO Ken Mobeck, and Chief Accounting Officer François Dietsch.
How can I participate in the conference call?
You can join the conference call by calling the designated domestic or international numbers provided in the announcement.
What is EDAP TMS’s main focus in the medical device industry?
EDAP TMS specializes in minimally invasive medical devices utilizing robotic energy-based therapies, particularly for urological conditions.
What is the Focal One system?
The Focal One system is EDAP’s leading product for prostate focal therapy, combining imaging and robotics for precision treatment.
About The Author
Contact Henry Turner privately here. Or send an email with ATTN: Henry Turner as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.